Telix Pharmaceuticals Limited American Depositary Shares (TLX) News Today $16.82 -0.02 (-0.12%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$16.24 -0.58 (-3.44%) As of 04/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy CandidateApril 15 at 6:37 PM | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 1.4% - Here's WhyTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 1.4% Higher - Here's What HappenedApril 9, 2025 | marketbeat.comTelix Announces Cardinal Health for Gozellix Commercial DistributionApril 8, 2025 | globenewswire.comTelix Appoints Paul Schaffer as Chief Technology OfficerApril 7, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sets New 52-Week Low - Time to Sell?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sets New 52-Week Low - Should You Sell?April 7, 2025 | marketbeat.comTelix Pharmaceuticals expects no 'material impact' from tariffsApril 7, 2025 | msn.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Should You Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume - What's Next?April 6, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - What's Next?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - Here's WhyApril 4, 2025 | marketbeat.comAnne Whitaker Appointed as Non-Executive DirectorApril 3, 2025 | globenewswire.comTelix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue SarcomaApril 1, 2025 | globenewswire.comARTMS Drug Master File for Gallium Production Technology Referenced with Telix's Gozellix®April 1, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 4.4% - Here's What HappenedTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Down 4.4% - Time to Sell?March 28, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Up 4.4% - Should You Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Up 4.4% - Still a Buy?March 22, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Still a Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Here's What HappenedMarch 21, 2025 | marketbeat.comTelix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening AgentMarch 21, 2025 | investopedia.comFDA Approves New Prostate Cancer Imaging Agent Gozellix®March 21, 2025 | globenewswire.comIlluccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaMarch 17, 2025 | globenewswire.comWhat is William Blair's Estimate for TLX FY2025 Earnings?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) - William Blair reduced their FY2025 earnings estimates for shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report issued to clients and investors on Wednesday, March 12th. WilliamMarch 15, 2025 | marketbeat.comResearch Analysts Set Expectations for TLX FY2027 EarningsTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) - Equities research analysts at William Blair lowered their FY2027 EPS estimates for Telix Pharmaceuticals Limited American Depositary Shares in a report released on Wednesday, March 12th. William Blair analyst A.March 14, 2025 | marketbeat.comWilliam Blair Reaffirms Outperform Rating for Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)William Blair reaffirmed an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday.March 13, 2025 | marketbeat.comTelix Adds Lead-212 Isotope Production CapabilityMarch 12, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - Time to Sell?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - Time to Sell?March 12, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Time to Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Time to Buy?March 11, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 4.3% - Here's WhyTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Up 4.3% - Here's What HappenedMarch 7, 2025 | marketbeat.comInvestor Webinar: Telix Therapeutics Urology Showcase and Expert ForumMarch 3, 2025 | globenewswire.comFDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority ReviewFebruary 25, 2025 | globenewswire.comRecruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in MiamiFebruary 25, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase - Should You Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Still a Buy?February 24, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sets New 52-Week High - What's Next?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Hits New 12-Month High - Still a Buy?February 23, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Should You Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Time to Buy?February 22, 2025 | marketbeat.comAustralia's Telix Pharmaceuticals scales record peak on upbeat revenue forecastFebruary 20, 2025 | reuters.comTelix Pharmaceuticals Limited 2024 Q4 - Results - Earnings Call PresentationFebruary 20, 2025 | seekingalpha.comTelix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 BillionFebruary 20, 2025 | globenewswire.comTelix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)February 13, 2025 | globenewswire.comIlluccix® Approved in the United KingdomFebruary 12, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume - Here's WhyTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Here's What HappenedFebruary 3, 2025 | marketbeat.comTelix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology PlatformJanuary 30, 2025 | globenewswire.comTelix Pharmaceuticals Limited: Telix Completes Acquisition of RLS (USA) Inc.January 28, 2025 | finanznachrichten.deTelix Completes Acquisition of RLS (USA) Inc.January 27, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase on Analyst UpgradeTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume Following Analyst UpgradeJanuary 27, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Expected to Rise, UBS Group Analyst SaysUBS Group increased their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Monday.January 27, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - What's Next?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Should You Buy?January 24, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume - Should You Buy?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume - Still a Buy?January 17, 2025 | marketbeat.comIlluccix® Receives European ApprovalJanuary 16, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Here's What HappenedTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Here's What HappenedJanuary 16, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 7.2% - What's Next?Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Up 7.2% - Here's What HappenedJanuary 14, 2025 | marketbeat.comTelix Presentation to the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13, 2025 | globenewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Hits New 12-Month Low - Here's What HappenedTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Hits New 52-Week Low - Time to Sell?January 13, 2025 | marketbeat.comTelix Exceeds FY24 Guidance with US$142M Q4 RevenueJanuary 13, 2025 | globenewswire.comTelix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology PlatformJanuary 12, 2025 | globenewswire.com Remove Ads Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address TLX Media Mentions By Week TLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLX News Sentiment▼0.790.78▲Average Medical News Sentiment TLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLX Articles This Week▼32▲TLX Articles Average Week Remove Ads Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News ITCI News SMMT News GMAB News RDY News MRNA News VTRS News QGEN News ASND News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLX Stock Free TLX Stock Alerts